Dr. Susan Carnell and her team are researching ways to treat or prevent obesity more effectively.
Child and Adolescent Psychiatry
Substance Use Disorder
Fraction of U.S. Outpatient Treatment Centers Offer Medication for Opioid Addiction
Released: January 15, 2019. Hopkins study found just six percent of medication-offering facilities offered all three FDA-approved medications to treat opioid use disorder: buprenorphine, naltrexone or methadone. Ideally, facilities should be offering any of these three medications to best meet a patient’s needs, as some patients may benefit more from methadone, others from buprenorphine and yet others from naloxone, extended release.
#TomorrowsDiscoveries: Preventing Obesity
Seeking Knowledge to Cure and Prevent
Our clinical research programs range from efficacy and treatment-response studies to clinical trials and epidemiology. Our basic research encompasses bioinformatics, genetics, neuroscience, neuroimaging, and molecular biology - all in an effort to unlock the causal pathways to the major psychiatric conditions and to use this knowledge to develop practical means to improve diagnosis and treatment.
The depth of our clinical expertise and the breadth of our research programs allow us to train the next generation of psychiatrists and scientists to be clinical and research leaders. Our educational programs include medical student education, a general psychiatry residency, a child and adolescent psychiatry residency, and post-doctoral fellowship and research training opportunities.Training Programs